Watch Demo

Germany Anti Rheumatic Industry Outlook 2022 - 2026

See how Germany Anti Rheumatic performed compared to key markets such as South Korea and Spain.

Key Market Indicators

Sales of German antirheumatic medicines are projected to fall slightly in the coming years, dropping 0.5% annually on average. This follows a downward trend that has been in place since 1991, when the country registered a 0.6% year-on-year decrease. In 2021, Germany’s antirheumatic medicine sales amounted to $605 million, making it the second-largest market worldwide. South Korea led the way with $634 million, followed by Spain ($564 million) and Canada ($507 million).

Marketing Banner

Germany Anti Rheumatic Market Data and Forecasts

How much will Germany Anti Rheumatic Market grow to 2026?

Forecast: Non-Steroids Antiinflammatory and Antirheumatic Medicine Sales in Germany
Forecast: Non-Steroids Antiinflammatory and Antirheumatic Medicine Sales in Germany
Forecast: Non-Steroids Antiinflammatory and Antirheumatic Medicine Use in Germany
Forecast: Non-Steroids Antiinflammatory and Antirheumatic Medicine Sales in Germany
Forecast: Non-Steroids Antiinflammatory and Antirheumatic Medicine Sales in Germany
More in Anti Rheumatic Industry for 2028